NANOSPECTRA BIOSCIENCES INC has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets medical technology, pharmaceuticals and micro-structure and nano-technology are MIRAVANT MEDICAL TECHNOLOGIES, THE BIONICS INST OF AUSTRALIA and PILL PHARMA LTD E.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Micro-structure and nano-technology | |
#4 | Optics | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Electrotherapy | |
#3 | Syringes | |
#4 | Therapeutic chemical compounds | |
#5 | Diagnosis and surgery | |
#6 | Nanostructure applications | |
#7 | Spectacles | |
#8 | Producing goods from plastic | |
#9 | Implantable devices | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Payne J Donald | 11 |
#2 | Goodrich Glenn Patrick | 6 |
#3 | Schwartz Jon Alexander | 6 |
#4 | Murphy Andrew Mark | 6 |
#5 | Krishnan Sunil | 4 |
#6 | Jackson Joseph B | 3 |
#7 | Glenn Patrick Goodrich | 3 |
#8 | Jon Alexander Schwartz | 3 |
#9 | Schwartz Jon A | 3 |
#10 | Diagaradjane Parmeswaran | 3 |
Publication | Filing date | Title |
---|---|---|
AU2017378412A1 | Devices and the use thereof in methods for ablation therapy | |
EP2555800A1 | Enhancement of radiation therapy by targeted high-z nanoparticles | |
WO2009117124A1 | Narrowband imaging using near-infrared absorbing nanoparticles | |
WO2009091597A2 | Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy | |
WO2008108980A2 | Devices and methods for extracorporeal ablation of circulating cells | |
EP2016458A1 | Plasmon resonant based eye protection | |
US2006275596A1 | Plasmon resonant based eye protection | |
AU2002365603A1 | Treatment of angiogenesis disorders using targeted nanoparticles |